| Minimal residual disease detection in acute lymphoblastic leukemia A Kruse, N Abdel-Azim, HN Kim, Y Ruan, V Phan, H Ogana, W Wang, ... International journal of molecular sciences 21 (3), 1054, 2020 | 125 | 2020 |
| Integrin Antibody Decreases Deformability of Patient‐Derived Pre‐B Acute Lymphocytic Leukemia Cells as Measured by High‐Frequency Acoustic Tweezers HC Liu, EJ Gang, HN Kim, N Abdel‐Azim, R Chen, H Abdel‐Azim, ... Journal of Ultrasound in Medicine 39 (3), 589-595, 2020 | 7 | 2020 |
| Dual targeting of PI3Kdelta and BRD4 sensitizes acute lymphoblastic leukemia to chemotherapy HN Kim, C Nichols, EJ Jiang, N Abdel-Azim, A Coba, DOL Durden, ... Blood 132, 1420, 2018 | 2 | 2018 |
| Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic Leukemia Y Ruan, HN Kim, HA Ogana, Z Wan, S Hurwitz, C Nichols, N Abdel-Azim, ... Frontiers in Oncology 11, 766888, 2021 | 1 | 2021 |
| Preclinical Evaluation of a Novel Dual Targeting PI3Kd/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic Leukemia Y Ruan, HN Kim, HA Ogana, Z Wan, S Hurwitz, C Nichols, N Abdel-Azim, ... Molecular and Immunological Advances in Hematological Malignancies: Volume II, 2022 | | 2022 |
| Cell Adhesion of ALL to Stromal Cells May Mediate CAR T-Cell Resistance: A Novel Escape Mechanism for Immunotherapy HN Kim, E Jiang, R Yongsheng, H Ogana, N Abdel-Azim, J Le, A Luong, ... Blood 134, 2623, 2019 | | 2019 |
| The PI3Kdelta Inhibitor, CAL-101, Inhibits Migration of Primary Pre-B ALL to SDF1alpha: Treatment Implications for Overcoming Cell-Adhesion-Mediated Drug Resistance EJ Gang, HN Kim, Y Duchartre, SN Shishido, S Khazal, E Adam, ... Blood 126 (23), 2526, 2015 | | 2015 |
